As with any medication, patients may experience: Mild to Moderate Nausea: Although it causes less nausea than other GLP-1 receptor agonists, some patients may still experience this symptom, especially when starting treatment
A Prime Therapeutics analysis (2024) found GLP-1 use raised annual healthcare costs by 46% for obese patients in two years versus controls ( [71] ), mainly driven by drug spending
GLP-1s are most well studied for weight loss (obesity) and blood sugar control (type 2 diabetes)
Hammer MS, Swinburn TK, Neitzel RL
When using fibre supplements, take them with plenty of water and separate them from other oral medicines by at least 2 hours to avoid potential interference with medication absorption
He, F., Chen, W., Xu, W., Liu, D., Xiao, Z., Tang, Y., Lin, Z., Liao, Y., Bin, J., Chen, G., & Chen, Y